These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8906311)

  • 1. Benzoylalanine analogues as inhibitors of rat brain kynureninase and kynurenine 3-hydroxylase.
    Giordani A; Corti L; Cini M; Marconi M; Pillan A; Ferrario R; Schwarcz R; Guidetti P; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():499-505. PubMed ID: 8906311
    [No Abstract]   [Full Text] [Related]  

  • 2. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase.
    Giordani A; Corti L; Cini M; Bormetti R; Marconi M; Veneroni O; Speciale C; Varasi M
    Adv Exp Med Biol; 1996; 398():531-4. PubMed ID: 8906317
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
    Carpenedo R; Chiarugi A; Russi P; Lombardi G; Carlà V; Pellicciari R; Mattoli L; Moroni F
    Neuroscience; 1994 Jul; 61(2):237-43. PubMed ID: 7969905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system.
    Moroni F; Carpenedo R; Chiarugi A
    Adv Exp Med Biol; 1996; 398():203-10. PubMed ID: 8906267
    [No Abstract]   [Full Text] [Related]  

  • 5. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
    Chiarugi A; Carpenedo R; Moroni F
    J Neurochem; 1996 Aug; 67(2):692-8. PubMed ID: 8764597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase.
    Chiarugi A; Carpenedo R; Molina MT; Mattoli L; Pellicciari R; Moroni F
    J Neurochem; 1995 Sep; 65(3):1176-83. PubMed ID: 7643095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.
    Pellicciari R; Natalini B; Costantino G; Mahmoud MR; Mattoli L; Sadeghpour BM; Moroni F; Chiarugi A; Carpenedo R
    J Med Chem; 1994 Mar; 37(5):647-55. PubMed ID: 8126705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase.
    Giordani A; Pevarello P; Cini M; Bormetti R; Greco F; Toma S; Speciale C; Varasi M
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2907-12. PubMed ID: 9873646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
    Miranda AF; Sutton MA; Beninger RJ; Jhamandas K; Boegman RJ
    Neurosci Lett; 1999 Mar; 262(2):81-4. PubMed ID: 10203236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine-3-hydroxylase and its selective inhibitors. Molecular modeling studies.
    Costantino G; Mattoli L; Moroni F; Natalini B; Pellicciari R
    Adv Exp Med Biol; 1996; 398():493-7. PubMed ID: 8906310
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
    Chiarugi A; Moroni F
    Neuropharmacology; 1999 Aug; 38(8):1225-33. PubMed ID: 10462134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.
    Moroni F; Cozzi A; Peruginelli F; Carpenedo R; Pellegrini-Giampietro DE
    Adv Exp Med Biol; 1999; 467():199-206. PubMed ID: 10721057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
    Röver S; Cesura AM; Huguenin P; Kettler R; Szente A
    J Med Chem; 1997 Dec; 40(26):4378-85. PubMed ID: 9435907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 28833, a selective kynurenine 3-hydroxylase inhibitor. Effects on the kynurenine pathway metabolites in the gerbil.
    Cini M; Bormetti R; Marconi M; Molinari A; Veneroni O; Varasi M; Schwarcz R; Speciale C
    Adv Exp Med Biol; 1996; 398():535-8. PubMed ID: 8906318
    [No Abstract]   [Full Text] [Related]  

  • 15. Amidepsine E, an inhibitor of diacylglycerol acyltransferase produced by Humicola sp. FO-5969.
    Tomoda H; Yamaguchi Y; Tabata N; Kobayashi T; Masuma R; Tanaka H; Omura S
    J Antibiot (Tokyo); 1996 Sep; 49(9):929-31. PubMed ID: 8931727
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase.
    Pellicciari R; Amori L; Costantino G; Giordani A; Macchiarulo A; Mattoli L; Pevarello P; Speciale C; Varasi M
    Adv Exp Med Biol; 2003; 527():621-8. PubMed ID: 15206781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents.
    Speciale C; Cini M; Wu HQ; Salvati P; Schwarcz R; Molinari A; Calabresi M; Varasi M
    Adv Exp Med Biol; 1996; 398():221-7. PubMed ID: 8906269
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening marine natural products for selective inhibitors of key kynurenine pathway enzymes.
    Feng Y; Bowden BF; Kapoor V
    Redox Rep; 2000; 5(2-3):95-7. PubMed ID: 10939281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.
    Cozzi A; Carpenedo R; Moroni F
    J Cereb Blood Flow Metab; 1999 Jul; 19(7):771-7. PubMed ID: 10413032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolo[3,2-c]quinoline derivatives: a new class of kynurenine-3-hydroxylase inhibitors.
    Heidempergher F; Pevarello P; Pillan A; Pinciroli V; Della Torre A; Speciale C; Marconi M; Cini M; Toma S; Greco F; Varasi M
    Farmaco; 1999 Mar; 54(3):152-60. PubMed ID: 10371028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.